Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort
Mohamad Maghnie(Istituto Giannina Gaslini), Adda Grimberg(Children's Hospital of Philadelphia), Elpis Vlachopapadopoulou(Panagiotis & Aglaia Kyriakou Children's Hospital), Renata Stawerska(Medical University of Lodz), Peter Clayton(Manchester Academic Health Science Centre), Martin Carlsson(Pfizer (United States)), Wayne S. Cutfield(University of Auckland), Agnès Linglart(Assistance Publique – Hôpitaux de Paris), Roy Gomez(Pfizer (Belgium)), Mitchell E. Geffner(Children's Hospital of Los Angeles), Feyza Darendelıler, Anita Hokken-Koelega(Erasmus MC - Sophia Children’s Hospital), Michael P. Wajnrajch(Pfizer (United States)), Michel Polak(Hôpital Necker-Enfants Malades), Lourdes Ibáñez(Hospital Sant Joan de Déu Barcelona), Kerstin Albertsson‐Wikland(University of Gothenburg), Michael B. Ranke(University Children's Hospital Tübingen), Toshiaki Tanaka(Foundation for Growth Science), Raoul Rooman, Helmuth‐Günther Dörr(University Medical Center Groningen), Reiko Horikawa(National Center For Child Health and Development)
Cited by 106
Related Papers
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
|Hormone Research in Paediatrics|2015|3.1k
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
|European Journal of Endocrinology|2017|1.1k
Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society
|The Journal of Clinical Endocrinology & Metabolism|2007|724
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721